What is causing the absent menstrual bleed in a woman two months after bilateral salpingectomy who is currently taking 100 mg oral progesterone daily in a 2‑week on/2‑week off cycle and has been off her period for only one week with a normal pelvic ultrasound?

Absent Withdrawal Bleed on Cyclic Progesterone After Bilateral Salpingectomy

The most likely cause is inadequate endometrial proliferation prior to progesterone administration, preventing sufficient endometrial buildup to generate withdrawal bleeding when progesterone is stopped. 1

Primary Mechanism

Progesterone-only therapy requires adequate estrogen-primed endometrium to produce withdrawal bleeding. Without sufficient endometrial proliferation during the "off" weeks, there is simply not enough tissue to shed when progesterone is withdrawn. 1

• The FDA label for progesterone explicitly demonstrates that in postmenopausal women receiving progesterone alone (without concurrent estrogen), withdrawal bleeding rates are minimal because the endometrium lacks estrogenic stimulation. 1
• In premenopausal women with secondary amenorrhea, progesterone 300-400 mg daily for 10 days induced withdrawal bleeding in only 73.8-76.8% of cases, meaning approximately 25% failed to bleed despite adequate progesterone dosing. 1
• Your patient's 100 mg daily dose is substantially lower than the 300-400 mg used in clinical trials to induce withdrawal bleeding, making inadequate endometrial response even more likely. 1

Why This Occurs in Your Patient

The bilateral salpingectomy itself does not cause hormonal changes, but the timing suggests this may be coincidental with other factors affecting endometrial development. 2

• Anovulation or inadequate follicular phase estrogen production during the "off" weeks prevents sufficient endometrial proliferation, leaving nothing to shed when progesterone is withdrawn. 3, 4
• The normal pelvic ultrasound with presumably thin endometrium (though you didn't specify the measurement) supports inadequate proliferation rather than structural pathology. 5
• One documented case showed a woman with normal estrogen levels who failed to menstruate after progesterone withdrawal due to insufficient endometrial development, despite having adequate systemic estrogen. 3

Critical Differential Diagnoses to Exclude

Before attributing this to functional causes, you must systematically rule out:

• Pregnancy – This is mandatory even with bilateral salpingectomy, as ectopic pregnancy remains possible and tubal surgery increases risk. 6, 7
• Hypothalamic amenorrhea – Assess for weight loss, excessive exercise, stress, or eating disorders that suppress GnRH pulsatility. 2
• Hyperprolactinemia – Check serum prolactin, as even mild elevation can suppress ovulation and endometrial development. 2
• Thyroid dysfunction – Obtain TSH, as both hypo- and hyperthyroidism disrupt menstrual cycles. 2
• Premature ovarian insufficiency – Though unlikely at 2 months post-surgery, check FSH and estradiol if age >35 or other risk factors present. 2
• Asherman syndrome – Unlikely with normal ultrasound, but consider if there was any intrauterine instrumentation around the time of surgery. 5

Diagnostic Workup

Obtain the following laboratory studies immediately:

• Serum β-hCG to definitively exclude pregnancy 6, 7
• Serum estradiol level (should be >50 pg/mL for adequate endometrial proliferation) 1
• TSH and prolactin 2
• FSH if premature ovarian insufficiency is suspected 2

Review the ultrasound report specifically for:

• Endometrial thickness (should be >5 mm to expect withdrawal bleeding; <5 mm indicates inadequate proliferation) 3
• Ovarian morphology to assess for polycystic ovaries or other abnormalities 3

Management Algorithm

If Pregnancy and Pathology Are Excluded:

First-line approach: Add exogenous estrogen to prime the endometrium before progesterone administration. 1, 2

• Prescribe conjugated estrogens 0.625 mg daily for days 1-25 of the cycle, with progesterone 200 mg daily added on days 16-25. 1
• This mimics the physiologic hormonal pattern and provides adequate endometrial proliferation for subsequent withdrawal bleeding. 1
• The FDA label demonstrates that this combination produces withdrawal bleeding in >90% of women, compared to minimal bleeding with progesterone alone. 1

Alternative if estrogen is contraindicated or declined:

• Increase progesterone dose to 300-400 mg daily for 10-14 days per cycle, which may overcome inadequate proliferation in some cases. 1
• However, this is less reliable than adding estrogen and still requires some baseline endometrial development. 1

If the patient desires contraception or cycle regulation:

• Consider switching to combined oral contraceptives (if medically eligible), which provide both estrogen and progestin in a reliable pattern. 7, 8
• The levonorgestrel IUD is highly effective for endometrial suppression but causes amenorrhea in only 22% of users, so may not address her concerns about absent bleeding. 2

Common Pitfalls to Avoid

• Do not assume the bilateral salpingectomy caused hormonal changes – this surgery does not affect ovarian function or hormone production. 2
• Do not continue the current regimen indefinitely without investigation – prolonged unopposed estrogen (even endogenous) without adequate progestin effect increases endometrial hyperplasia risk, though your patient's thin endometrium suggests this is not currently occurring. 1
• Do not attribute absent bleeding to "stress from surgery" without excluding organic causes – stress-related amenorrhea typically affects the hypothalamic-pituitary axis and would present with anovulation, not isolated failure of withdrawal bleeding. 9
• Do not overlook medication interactions – review all medications, supplements, and herbal products, as some can interfere with hormone metabolism or endometrial response. 7

Expected Timeline

• If estrogen is added to the regimen, expect withdrawal bleeding within 2-7 days after stopping both hormones in the first cycle. 1
• If bleeding does not occur after two cycles of adequate estrogen-progesterone therapy, further evaluation for endometrial pathology or Asherman syndrome is warranted despite the normal ultrasound. 5, 2